Building Powerful Partnerships
For Powerful Medicine
Promising science needs strong backing to move forward. We work with individual scientists and innovative research institutions to keep great discoveries moving through the toughest phases of the research pipeline.
We’re finding innovative pre-clinical research, then partnering with scientists to turn promising inventions into clinical ready assets, one great discovery at a time.
Institutional
affiliations
In 2021, great science is almost always born in an environment that fosters strong collaboration. Our experience tells us that great science tends to cluster: within groundbreaking labs, within departments that push boundaries, within universities that are powerfully led. Our unique partnership model allows universities and research institutes to set up long term backing that can accelerate promising discoveries and keep research funds cycling.
Dr. Jack Elias
Dean of Biology and Medicine
Brown University Alpert School of Medicine
Licensed: 3 preclinical assets in pulmonary cancer and fibrosis treatment
When the former Yale University infectious disease specialist came to Brown University in 2013, he was able to accelerate his lab research on underlying pulmonary mechanisms, leading to groundbreaking discoveries that are on the verge of phase one trials for 3 new medicines.
Dr. Jake Kurtis
Chair of Pathology and Laboratory Medicine, Brown University
Licensed: 2 preclinical assets in malaria treatment and prevention
For 25 years Jake Kurtis has worked to find a cure for one of history’s most deadly and intractable diseases, malaria. Using a unique approach to isolate antigens, Dr. Kurtis has succeeded in discovering new approaches that have the potential to change malaria treatment worldwide, and drastically reduce child mortality rates in dozens of struggling countries.